New Key Statistics Module, Z-Score and F-Score
NAS:CRSP Key Ratios
| Market Cap $ M | 3,315.98 |
| Enterprise Value $ M | 1,679.58 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.71 |
| Price/Sales | 15.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 200.00 |
| EPS (TTM) $ | -2.80 |
| Beneish M-Score | -2.25 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.05 |
| EV-to-EBITDA | -5.36 |
| PEG | -- |
| Shares Outstanding M | 85.35 |
| Net Margin (%) | -119.80 |
| Operating Margin % | -166.20 |
| Pre-tax Margin (%) | -118.24 |
| Quick Ratio | 21.64 |
| Current Ratio | 21.64 |
| ROA % (ttm) | -10.55 |
| ROE % (ttm) | -12.46 |
| ROIC % (ttm) | -91.77 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.33 |
CRSP Number of Guru Trades
CRSP Volume of Guru Trades
Gurus Latest Trades with NAS:CRSP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CRSP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CRISPR Therapeutics AG Insider Transactions
No Available Data
News about NAS:CRSP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers